New study shows that (β)-Cannabichromene activates CB2 receptors π§ , while (+)-CBC does not. Both enantiomers activate TRPA1 receptors, but (β)-CBC is the more effective isomer for targeting cannabinoid receptors.
π Read more: https://t.co/BxVuqavYSX
πΏ #Cannabinoids#CBC
@Pharmechanic@zenbrainest@brightmindsbio hesitate to enter conversation ... but what about cellular/circuit adaptations to chronic G protein activation ... or is that a feature, not a bug ? ... returns to 199X and thinks about opioids ...
Exciting to see this project move into the construction phase. Itβs a complex beast, but will build critical capacity for NSW and Australia in this rapidly emerging technology
New paper from Mike Udoh & our colleagues at Baymedica, identifying the CB2-active isomer of CBC ... watch this space for more chiral surprises ... Activation of CB2 Receptors by (β)-Cannabichromene but Not (+)-Cannabichromene | C&CR, https://t.co/eiZ6kBqc6l
New paper from Mike Udoh & our colleagues at Baymedica, identifying the CB2-active isomer of CBC ... watch this space for more chiral surprises ... Activation of CB2 Receptors by (β)-Cannabichromene but Not (+)-Cannabichromene | C&CR, https://t.co/eiZ6kBqc6l
@Nnedi What with that and the Kookas, is it time for a visit to see them in their natural environment ... wouldn't even have to leave Sydney suburbia to see both (or not see the frogmouths, they are pretty hard to spot)